TransMedics (TMDX) Chief Commercial Officer files Form 3 showing no stock owned

Rhea-AI Filing Summary

TransMedics Group, Inc. filed an initial ownership report for executive Giovanni Cecere, who serves as Chief Commercial Officer. This Form 3 states that no securities are beneficially owned, meaning Cecere reports holding no TransMedics Group stock or derivative securities as of the event date.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Cecere Giovanni

(Last) (First) (Middle)

C/O TRANSMEDICS GROUP, INC.

200 MINUTEMAN ROAD

(Street)

ANDOVER MA 01810

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/02/2026

3. Issuer Name and Ticker or Trading Symbol
TransMedics Group, Inc. [ TMDX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List Exhibit 24 - Limited Power of Attorney

No securities are beneficially owned.

	By: /s/ Gerardo Hernandez, Attorney-in-Fact	02/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the TransMedics (TMDX) Form 3 filing for Giovanni Cecere show?

The Form 3 shows that Chief Commercial Officer Giovanni Cecere reports no beneficial ownership of TransMedics Group securities. This covers both common stock and derivative securities as of the stated event date in the filing.

Who is the reporting person in the TransMedics (TMDX) Form 3?

The reporting person is Giovanni Cecere, identified as the Chief Commercial Officer of TransMedics Group, Inc. The filing confirms his officer status and provides an initial snapshot of his reported holdings in company securities.

Does the TransMedics (TMDX) Form 3 report any stock owned by Giovanni Cecere?

No. The Form 3 explicitly notes that no securities are beneficially owned by Giovanni Cecere. Both the non-derivative and derivative securities tables contain no reported holdings, indicating a zero-ownership position at the time of filing.

Are there any transactions reported in the TransMedics (TMDX) Form 3 for Giovanni Cecere?

No transactions are reported. The Form 3 serves as an initial ownership statement and, in this case, shows no beneficial ownership and includes no entries for purchases, sales, or grants of TransMedics Group securities.

What role does the attorney-in-fact play in the TransMedics (TMDX) Form 3 filing?

The Form 3 is signed by Gerardo Hernandez as Attorney-in-Fact under a Limited Power of Attorney. This means Hernandez is authorized to execute the ownership report on behalf of Giovanni Cecere for SEC compliance purposes.